(@immunotherapyirc.bsky.social)

Treatment-free Remission in Chronic Myeloid Leukemia in Low- and Middle-Income Countries | NEJM www.nejm.org/doi/10.1056/... Tyrosine kinase inhibitor drugs can be highly effective against CML. Authors report barriers to access in low- and middle-income countries can be overcome. @fredhutch.org

loading . . .

Treatment-free Remission in Chronic Myeloid Leukemia in Low- and Middle-Income Countries | NEJM In an evaluation in low- and middle-income countries involving 95 patients with chronic myeloid leukemia who had deep remission for more than 1 year, 79% remained in treatment-free remission after ... https://www.nejm.org/doi/10.1056/NEJMc2518028